Policies

• Publication Ethics

  
  

  The Chinese Pediatrics of Integrated Traditional and Western Medicine adheres to the recognized publishing ethical standards of relevant international organizations (e.g., ICMJE, COPE, etc.) and strongly opposes any form of plagiarism. The journal’s editors, authors, and reviewers should fulfill the following responsibilities (but are not limited to these) and comply with other journal requirements.

  
  

  I. Responsibilities of Authors

  The main responsibilities of authors include:

  1. The authorship of the manuscript must meet the journal's authorship criteria, meaning the authors must have substantially contributed to the research or related work, including: the conception and design of the study, acquisition of research data, analysis and interpretation of research data, writing the article, or making critical revisions to important content. Providers of laboratory facilities or funding cannot be listed as authors. Any addition, removal, or change of authors before publication must be accompanied by a handwritten signed permission letter from the first author and corresponding author, stamped with the institution's seal.

  2. Authors commit that their manuscript does not involve plagiarism, fabrication, or falsification of research data. The manuscript has not been published in any form or language in any media, in China or abroad, and has not been submitted to multiple journals simultaneously. After publication, it will not be submitted to other journals in any language.

  3. If the manuscript uses others' research results, clear attribution must be given, and permission must be obtained from the original authors in accordance with copyright law to avoid infringing on others' intellectual property rights. In case of copyright disputes, the author assumes full responsibility.

  4. Authors ensure that their manuscript does not involve state-related confidential content or infringe on the interests of other organizations or individuals. Otherwise, the author assumes responsibility.

  5. The corresponding author should ensure that all major contributors are listed as co-authors and that no contributors are omitted. Only after all authors agree can the manuscript be submitted. Those who contributed to the research but are not authors should be acknowledged.

  6. Authors must declare their individual contributions to the research and any potential conflicts of interest. Authors must fill out and submit the journal's "Authors Statement Form." A potential conflict of interest exists when the financial/personal/affiliative relationships of the author (or their institution/employer) may influence the author's decisions, work, or manuscript. If the manuscript mentions specific products, the author should also disclose any conflicts of interest with competing products.

  7. Issues of medical ethics and informed consent must adhere to the basic principles of medical ethics. When the subject of the paper involves human participants, the authors should specify whether their procedures comply with the ethical standards set by the responsible committee for human trials (institutional, regional, or national). Approval documents from this committee must be provided (approval number should be included in the paper). Ensure that the participants or their family members have signed informed consent forms, although the consent form does not need to be submitted to the editorial office. Authors must pay attention to protecting patient privacy, including covering faces and avoiding the exposure of personal information such as names or identification numbers in specimen and imaging images. When reporting animal experiments, there should be written proof from the relevant ethics committee that the experiments complied with animal welfare regulations, and this should be stated in the paper.

  8. For all clinical trial research (prospective studies), authors are generally required to register with the WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/) or the Chinese Clinical Trial Registry (http://www.chictr.org.cn/) and indicate the clinical trial registration number in the manuscript.

  
  

  II. Responsibilities of Editors

  The main responsibilities of editors (including editorial board members) include:

  1. Editors should base their decisions on the scientific value of the articles, irrespective of the authors' affiliations, nationalities, races, genders, ages, or other personal characteristics.

  2. Editors should make every effort to ensure a fair and timely review process for submitted manuscripts.

  3. Manuscripts should be handled confidentially. Details should not be disclosed to anyone other than the reviewers without the authors' permission.

  4. Potential conflicts of interest should be promptly disclosed to the editorial office:

     1) If the editor is the author of a manuscript, it must be reviewed independently by another editor.

     2) If there is a conflict of interest between the editor and the author (such as colleagues, teacher-student relationships, collaboration, competition), the manuscript must be handled by another editor.

     3) If the research topic is too close to the editor's own projects, the manuscript should be transferred to another editor.

  5. Editors should carefully select reviewers to ensure a fair review process:

     1) Caution should be exercised when using reviewers recommended by the authors to avoid excessive affirmation (e.g., avoiding reviewers who are former supervisors, students, or co-authors of the authors).

     2) The identity of recommended reviewers should be verified to ensure the fairness of the peer review process.

     3) Editors should avoid selecting reviewers who the authors have requested to be excluded.

  6. Editors should fairly and thoroughly investigate and handle appeals against review decisions.

  7. Editors should rigorously examine manuscripts for academic misconduct. If allegations of misconduct are raised, editors should promptly investigate and address them.

  
  

  III. Responsibilities of Reviewers

  Reviewers, who assist the editorial office in reviewing manuscripts, should be experts in the relevant field. Their main responsibilities include:

  1. Reviewers should maintain confidentiality regarding the manuscript's content and the review process:

      1) Data, information, arguments, and other content in the manuscript must not be shared with others without authorization.

      2) The identity of the reviewer and details of the review process must not be disclosed to others.

      3) After completing the review, reviewers should not retain the manuscript in any form and must comply with data protection regulations.

  2. Reviewers should not use data, results, or other confidential information from the manuscript under review for their own research.

  3. If a reviewer has a conflict of interest with the authors (e.g., colleagues, teacher-student relationships, collaboration, competition), they should recuse themselves from reviewing the manuscript.

  4. Reviewers should conduct reviews in a timely manner. If unable to complete the review or requiring more time, they should notify the editorial office immediately.

  5. Reviewers should provide detailed and objective assessments and offer fair and impartial opinions.

  6. Reviewers should provide professional and polite feedback on manuscripts, avoiding personal criticism of the authors.

  7. If reviewers find similarities between the manuscript under review and other published or unpublished articles, they should notify the editorial office.

  8. If reviewers discover potential ethical issues in the manuscript, they should promptly inform the editorial office. This includes, but is not limited to, academic misconduct such as plagiarism, data fabrication, and ethical issues related to human or animal experiments or research.

  
  

  IV. Intellectual Property Protection and Open Science
  The editorial office strives to respect the protection of intellectual property and requires editors, authors, and reviewers to do the same. Any potential infringement should be avoided. Third-party organizations must also respect the journal's intellectual property and refrain from infringement. While ensuring the protection of intellectual property, the journal encourages open science practices, including the publication and sharing of research data where appropriate. Data that can be shared typically includes raw data, observational records, experimental results, etc. The journal also encourages authors to share software, code, models, algorithms, protocols, methods, and other relevant materials. Authors may upload these materials to accessible third-party storage platforms and include the link as an attachment at the end of the manuscript.

  
  

  V. Policies on Generative Artificial Intelligence Technology
  Generative Artificial Intelligence (GenAI) technology lacks critical thinking and originality assessment capabilities, and may generate conclusions that are unrigorous, incomplete, or biased. As non-legal entities, they cannot assess conflicts of interest and are not eligible to sign copyright transfer agreements. Therefore, the journal prohibits using GenAI as an author and for writing key parts of a manuscript (such as research methods, result analysis, etc.). If GenAI is used, authors must disclose it in the research methods section and take responsibility for the generated content. The editorial office also does not allow the use of GenAI for assisting manuscript review and acceptance decisions. The review and editing process must be conducted by humans, and manuscripts and supplementary materials must not be uploaded to publicly accessible GenAI platforms.

  
  

  VI. Advertising Policy
  The print version of the journal contains advertisements. The journal declares that advertisement content must be reasonable and legal, and that advertisements will be presented separately from academic content. Advertising placement will not affect the editorial process or acceptance decisions. In the event of a conflict of interest, it will be handled according to the journal’s relevant guidelines.

  
  

2024-08-01 Visited: 148